Redx Pharma Plc operates as a drug discovery and development company in the United Kingdom. It focuses on the development of small molecule therapeutics for cancer, immunology, and infection. The company is developing RXC004 Porcupine inhibitor, a potent inhibitor for pancreatic, biliary, and gastric cancers; and RXC005, a reversible Bruton's Tyrosine Kinase inhibitor for a range of blood cancers, such as chronic lymphocytic leukaemia. It has research collaboration with AstraZeneca. Redx Pharma Plc was founded in 2010 and is based in Macclesfield, the United Kingdom.
Industry, Sector and Symbol
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
SymbolLON:REDX
CUSIPN/A
Phone+44-151-7064747
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins40.10%
Return on Equity294.97%
Return on Assets123.97%
Miscellaneous
EmployeesN/A
Outstanding Shares126,480,000
Redx Pharma (LON:REDX) Frequently Asked Questions
What is Redx Pharma's stock symbol?
Redx Pharma trades on the London Stock Exchange (LON) under the ticker symbol "REDX."
How were Redx Pharma's earnings last quarter?
Redx Pharma PLC (LON:REDX) posted its quarterly earnings results on Wednesday, May, 30th. The company reported ($3.60) earnings per share for the quarter. Redx Pharma had a return on equity of 294.97% and a net margin of 40.10%. View Redx Pharma's Earnings History.
Who are some of Redx Pharma's key competitors?
Some companies that are related to Redx Pharma include BELLUS Health (BLU), Medicenna Therapeutics (MDNA), Destiny Pharma (DEST), NovaBay Pharmaceuticals (NBY), Rexahn Pharmaceuticals (RNN), Abzena (ABZA), OptiBiotix Health (OPTI), Scancell (SCLP), Synthetic Biologics (SYN), DiaMedica Therapeutics (DMA), Antibe Therapeutics (ATE), Biopharmx (BPMX), Realm Therapeutics (RLM), Ceapro (CZO) and Nuvo Pharmaceuticals (NRI).
Who are Redx Pharma's key executives?
Redx Pharma's management team includes the folowing people:
- Mr. Iain Gladstone Ross, Exec. Chairman (Age 64)
- Mr. Dominic Nicholas Jackson, CFO & Exec. Director (Age 37)
- Dr. Richard Armer, Chief Scientific Officer
- Mr. Nicholas Adams BSc, Chief Bus. Officer (Age 54)
- Dr. Andrew Saunders, Chief Medical Officer (Age 53)
Has Redx Pharma been receiving favorable news coverage?
Press coverage about REDX stock has trended somewhat positive recently, according to Accern. The research firm identifies negative and positive media coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Redx Pharma earned a media sentiment score of 0.18 on Accern's scale. They also gave news coverage about the company an impact score of 47.89 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the immediate future.
How do I buy shares of Redx Pharma?
Shares of REDX and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Redx Pharma's stock price today?
One share of REDX stock can currently be purchased for approximately GBX 10.88.
How big of a company is Redx Pharma?
Redx Pharma has a market capitalization of £14.09 million.
How can I contact Redx Pharma?
Redx Pharma's mailing address is Block 33, Mereside,, Alderley Park, MACCLESFIELD, SK10 4TG, United Kingdom. The company can be reached via phone at +44-151-7064747.
MarketBeat Community Rating for Redx Pharma (REDX)
MarketBeat's community ratings are surveys of what our community members think about Redx Pharma and other stocks. Vote "Outperform" if you believe REDX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe REDX will underperform the S&P 500 over the long term. You may vote once every thirty days.
